Research Solutions Inc. (NASDAQ:RSSS – Get Free Report) was the recipient of a large decrease in short interest during the month of July. As of July 15th, there was short interest totaling 65,614 shares, a decrease of 35.8% from the June 30th total of 102,245 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily volume of 30,438 shares, the short-interest ratio is presently 2.2 days.
Institutional Trading of Research Solutions
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Rothschild Wealth LLC acquired a new position in Research Solutions in the 4th quarter worth approximately $1,049,000. North Star Investment Management Corp. acquired a new stake in Research Solutions during the 1st quarter valued at approximately $754,000. Navalign LLC lifted its stake in Research Solutions by 154.7% during the 1st quarter. Navalign LLC now owns 251,126 shares of the company’s stock valued at $568,000 after acquiring an additional 152,546 shares during the period. Hillsdale Investment Management Inc. purchased a new stake in shares of Research Solutions in the 4th quarter valued at $288,000. Finally, Punch & Associates Investment Management Inc. boosted its holdings in shares of Research Solutions by 3.4% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 2,499,310 shares of the company’s stock valued at $9,322,000 after acquiring an additional 81,210 shares during the last quarter. Institutional investors and hedge funds own 33.60% of the company’s stock.
Analyst Ratings Changes
Several brokerages recently weighed in on RSSS. Lake Street Capital dropped their target price on Research Solutions from $5.00 to $4.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Roth Capital reiterated a “buy” rating and issued a $3.50 price target on shares of Research Solutions in a research note on Friday, May 15th. Weiss Ratings downgraded Research Solutions from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, May 15th. Finally, Maxim Group lowered their price target on Research Solutions from $5.00 to $4.00 and set a “buy” rating for the company in a report on Friday, May 15th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $3.83.
Research Solutions Trading Down 0.9%
NASDAQ RSSS opened at $2.20 on Friday. The company has a fifty day simple moving average of $2.25 and a two-hundred day simple moving average of $2.41. The stock has a market cap of $73.59 million, a P/E ratio of 15.72 and a beta of 0.74. Research Solutions has a 12-month low of $2.00 and a 12-month high of $4.12.
Research Solutions (NASDAQ:RSSS – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $12.12 million for the quarter, compared to analyst estimates of $12.37 million. Research Solutions had a return on equity of 27.45% and a net margin of 9.28%. As a group, sell-side analysts forecast that Research Solutions will post 0.09 earnings per share for the current year.
Research Solutions Company Profile
Research Solutions, Inc (NASDAQ:RSSS) is a provider of software and managed services that streamline access to and management of scientific, technical and medical research. The company’s flagship platform automates the acquisition, licensing and delivery of journal articles, conference proceedings and other pay-walled content, enabling institutions to reduce administrative overhead and control subscription costs.
Key offerings include self-service workflows for document requests, enterprise-grade managed services for high-volume users, and analytics tools that deliver detailed reporting on spend, usage patterns and supplier performance.
Featured Stories
- Five stocks we like better than Research Solutions
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
